Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 07, 2020

SELL
$54.34 - $94.85 $1.03 Million - $1.79 Million
-18,881 Closed
0 $0
Q2 2020

Jul 17, 2020

BUY
$29.67 - $80.0 $560,199 - $1.51 Million
18,881 New
18,881 $1.21 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pennsylvania Capital Management Inc Portfolio

Follow Pennsylvania Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pennsylvania Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Pennsylvania Capital Management Inc with notifications on news.